Quinones can in principle be viewed as a double-edged sword in the treatment of
neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic …

So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only
approved drugs attenuate some symptoms, but do not halt the progress of this disease …

Alzheimer's disease (AD) is a prevalent neurodegenerative disease characterized by both
amnestic and non-amnestic clinical manifestations. It accounts for approximately 60-70% of …

Alzheimer's disease (AD) is the most common form of dementia. It increases the risk of other
serious diseases and causes a huge impact on individuals, families, and socioeconomics …

Alzheimer's disease (AD) is a progressive brain disorder associated with slow loss of brain
functions leading to memory failure and modest changes in behavior. The multifactorial …

Efficient multi-targeted intervention of complex pathogenic factors may hold promises for
Alzheimer's disease (AD) treatment due to the continuous failure of single-targeted therapy …

Glutamate-induced neurotoxicity in the HT22 mouse hippocampal neuronal cell line has
been recognized as a valuable cell model for the study of neurotoxicity associated with …

Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …

Over the past 30 years, the majority of (pre) clinical efforts to find an effective therapy for
Alzheimer's disease (AD) focused on clearing the β-amyloid peptide (Aβ) from the brain …

(1) Background: Alzheimer's disease (AD) is a progressive and fatal neurodegenerative
disorder. Hydrogen gas (H2) is a therapeutic medical gas with multiple functions such as …